A phase I trial assessing the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of single-dose Auron Misheil therapy in healthy male subjects
Journal of Clinical Pharmacy and Therapeutics, 05/04/2012
Scheele J et al. – These data provide important pharmacokinetic (PK), pharmacodynamic (PD) and safety data for auron misheil therapy (AMT), and support further controlled clinical investigation in patients with different types of cancer as an option for supportive care.



